Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Axera Pharma Private Limited, is an unlisted private company incorporated on 27 April, 2005. It is classified as a private limited company and is located in , Maharashtra. It's authorized share capital is INR 1.00 lac and the total paid-up capital is INR 1.00 lac.
The current status of Axera Pharma Private Limited is - Converted to LLP.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2024 numbers.
9.29%
7.69%
-68.97%
2.15%
6.23%
5.07%
5.57
-0.31
-8.37
-8.01
-0.76
0.01
No Reports Available
Tofler currently has no financial reports
for this company due to a lack of available
information. This may be because the company
is dormant or closed (see company status)
or because it was formed only recently
(check the incorporation date) and financial data
is not yet available.
You can view basic information by scrolling through the page.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(1)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Smriti Rajesh Agrawal | 00075064 | 11 years |
| Director | Aayush Madhusudan Agrawal | 03129764 | 14 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| SWADESH CAPITAL PRIVATE LIMITED |
Active
|
5.0 L | 1 | Maharashtra |
| RITEAID FINANCE PRIVATE LIMITED |
Active
|
9.0 L | 1 | Maharashtra |
| ALMIRON PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| GLEAMIO TRADING PRIVATE LIMITED |
Strike Off
|
1.0 L | 2 | Maharashtra |
| GENCREST PRIVATE LIMITED |
Converted to LLP
|
10.0 L | 1 | Maharashtra |
| AXERA ENTERPRISES PRIVATE LIMITED |
Active
|
10,000.0 | 1 | Maharashtra |
| ILLUMA OPTHALMACEUTICALS PRIVATE LIMITED |
Converted to LLP
|
1.0 L | 1 | Maharashtra |
| SUNDER AJANTA INFRASTRUCTURES LIMITED |
Converted to LLP
|
1.2 Cr | 2 | Maharashtra |
| VETRIUM HEALTH PRIVATE LIMITED |
Converted to LLP
|
1.0 L | 2 | Maharashtra |
| NUVENTA PHARMA PRIVATE LIMITED |
Converted to LLP
|
1.0 L | 1 | Maharashtra |
| ALMIRON PHARMA PRIVATE LIMITED |
Converted to LLP
|
1.0 L | 2 | Maharashtra |
| SUNCITY COMMODITIES PRIVATE LIMITED |
Active
|
32.0 L | 2 | West Bengal |
| AVECIA PHARMA PRIVATE LIMITED |
Converted to LLP
|
1.0 L | 1 | Maharashtra |
| NUVENTA PHARMA LLP |
Under Process Of Strike Off
|
1.0 L | 2 | Maharashtra |
| CDC PHARMA LLP |
Strike Off
|
1.0 L | 2 | Maharashtra |
| AVECIA PHARMA LLP |
Active
|
1.0 L | 2 | Maharashtra |
| AUREUS PHARMA LLP |
Active
|
1.0 L | 2 | Maharashtra |
| ZILLION LABS LLP |
Active
|
1.0 L | 2 | Maharashtra |
| AXERA PHARMA LLP |
Under Process Of Strike Off
|
1.0 L | 2 | Maharashtra |
| RENAMAX LABS LLP |
Under Process Of Strike Off
|
1.0 L | 2 | Maharashtra |
| ANSCA DERMACEUTICALS LLP |
Under Process Of Strike Off
|
1.0 L | 2 | Maharashtra |
| ANVAXX LABORATORIES LLP |
Active
|
1.2 L | 2 | Maharashtra |
| ILLUMA OPTHALMACEUTICALS LLP |
Strike Off
|
1.0 L | 2 | Maharashtra |
| VETRIUM HEALTH LLP |
Strike Off
|
1.0 L | 2 | Maharashtra |
| ALMIRON PHARMA LLP |
Active
|
1.0 L | 2 | Maharashtra |
| RITEAID ENTERPRISES LLP |
Active
|
1.0 L | 1 | Maharashtra |
| GANGA BUILDERS PRIVATE LIMITED |
Active
|
14.3 L | 1 | Maharashtra |
| VYATA SPACE CONCEPTS PRIVATE LIMITED |
Active
|
5.0 L | 1 | Maharashtra |
| INSPIRA LIVING CONCEPTS PRIVATE LIMITED |
Strike Off
|
5.0 L | 1 | Maharashtra |
| CDC PHARMA PRIVATE LIMITED |
Converted to LLP
|
1.0 L | 1 | Maharashtra |
| ZILLION LABS PRIVATE LIMITED |
Converted to LLP
|
1.0 L | 1 | Maharashtra |
| ANSCA DERMACEUTICALS PRIVATE LIMITED |
Converted to LLP
|
1.0 L | 1 | Maharashtra |
| RENAMAX LABS PRIVATE LIMITED |
Converted to LLP
|
1.0 L | 1 | Maharashtra |
| INSPIRA PROJECTS LIMITED |
Active
|
70.9 L | 1 | Maharashtra |
| INSPIRA ENERGY LIMITED |
Strike Off
|
5.0 L | 1 | Maharashtra |
| KWERA LANDS PRIVATE LIMITED |
Active
|
5.0 L | 1 | Maharashtra |
| AUREUS PHARMA PRIVATE LIMITED |
Converted to LLP
|
1.0 L | 1 | Maharashtra |
| INSPIRA SOLAR PRIVATE LIMITED |
Strike Off
|
5.0 L | 1 | Maharashtra |
| GABS INVESTMENTS PRIVATE LIMITED |
Active
|
1.8 L | 1 | Maharashtra |
| FAIRDEAL AVASON PRIVATE LIMITED |
Active
|
30.4 L | 1 | Maharashtra |
| INSPIRA SOLAR ENERGY PRIVATE LIMITED |
Strike Off
|
5.0 L | 1 | Maharashtra |
| INSPIRA INFRA (AURANGABAD) LIMITED |
Active
|
14.0 Cr | 1 | Maharashtra |
| INSPIRA REALTY & INFRA PRIVATE LIMITED |
Active
|
1.0 Cr | 1 | Maharashtra |
| IR JPV ESTATES PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| INSPIRA BUILDCON PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| INSPIRA EXIM ENTERPRISE PRIVATE LIMITED |
Active
|
11.0 Cr | 1 | Maharashtra |
| INSPIRA SIGNET (I) PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| INSPIRA DEVELOPERS PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| SEVA HOME COLLECTION PRIVATE LIMITED |
Active
|
10.0 L | 1 | Maharashtra |
| IR JPV REALTY LLP |
Active
|
10.0 L | 1 | Maharashtra |
| Inspira Estate LLP |
Active
|
1.0 L | 1 | sh |
| Inspira Bay LLP |
Active
|
1.0 L | 1 | sh |
| INSPIRA INDUSTRIES INDIA LLP |
Active
|
1.1 Cr | 1 | Maharashtra |
| INSPIRA REALTY LLP |
Active
|
5.3 Cr | 1 | Maharashtra |
| LENEXIS FOODWORKS PRIVATE LIMITED |
Active
|
24.0 Cr | 1 | Maharashtra |
The incorporation date of AXERA PHARMA PRIVATE LIMITED is 27 April, 2005
The authorized share capital of AXERA PHARMA PRIVATE LIMITED is INR ₹ 1.0 L.
The paid-up capital of AXERA PHARMA PRIVATE LIMITED is INR ₹ 1.0 L.
The registered address of AXERA PHARMA PRIVATE LIMITED is AJANTA HOUSEKANDIVLI (W) MUMBAI Maharashtra - 400067
The CIN number of AXERA PHARMA PRIVATE LIMITED is U24230MH2005PTC152841.
Expand
Delete
Collapse
See
details
